BioGaia AB (Sweden) Today
| BIOG-B Stock | SEK 116.90 1.90 1.60% |
PerformanceModest
| Odds Of DistressLow
|
BioGaia AB is trading at 116.90 as of the 19th of March 2025, a 1.6% down since the beginning of the trading day. The stock's open price was 118.8. BioGaia AB has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 97.28 M outstanding shares. More on BioGaia AB
Moving against BioGaia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioGaia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioGaia AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioGaia AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
BioGaia AB (BIOG-B) is traded on Stockholm Exchange in Sweden and employs 212 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioGaia AB's market, we take the total number of its shares issued and multiply it by BioGaia AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioGaia AB operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 97.28 M outstanding shares.
BioGaia AB has accumulated about 1.48 B in cash with 318.94 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.18.
Check BioGaia AB Probability Of Bankruptcy
Ownership AllocationBioGaia AB holds a total of 97.28 Million outstanding shares. Over half of BioGaia AB's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in BioGaia AB. Please watch out for any change in the institutional holdings of BioGaia AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioGaia Ownership Details
BioGaia AB Risk Profiles
Although BioGaia AB's alpha and beta are two of the key measurements used to evaluate BioGaia AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.18 | |||
| Semi Deviation | 1.23 | |||
| Standard Deviation | 1.61 | |||
| Variance | 2.6 |
BioGaia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioGaia AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
BioGaia AB Corporate Management
Elected by the shareholders, the BioGaia AB's board of directors comprises two types of representatives: BioGaia AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioGaia. The board's role is to monitor BioGaia AB's management team and ensure that shareholders' interests are well served. BioGaia AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioGaia AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gianfranco Grompone | Chief RD | Profile | |
| Eva Nelson | Co Mang | Profile | |
| Sebastian Heimfors | VP Officer | Profile | |
| MBA Econ | Founder Chairman | Profile | |
| Isabelle Ducellier | CEO Pres | Profile | |
| Marika Isberg | Regulatory Legal | Profile | |
| Angelika Kjelldorff | VP HR | Profile |
Other Information on Investing in BioGaia Stock
BioGaia AB financial ratios help investors to determine whether BioGaia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioGaia with respect to the benefits of owning BioGaia AB security.